NCT02875678View on ClinicalTrials.gov

A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia

PHASE1TerminatedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

November 22, 2016

Primary Completion Date

August 7, 2017

Study Completion Date

August 7, 2017

Conditions

Dyspepsia

Interventions

DRUG

ABX-1431

Single-dose ABX-1431

DRUG

Placebo

Single-dose matching placebo

Trial Locations (1)

Unknown

UZ Leuven, Leuven

Sponsors

Lead Sponsor

Abide Therapeutics

All Listed Sponsors

lead

Abide Therapeutics

INDUSTRY

NCT02875678 - A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia | Biotech Hunter | Biotech Hunter